Joseph P. Neglia
University of Minnesota
284 Papers
1.7K Citations
Joseph P. Neglia is an academic researcher from University of Minnesota. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 72, co-authored 241 publications. Previous affiliations of Joseph P. Neglia include Children's Oncology Group & Fred Hutchinson Cancer Research Center.
Chat about Author
Papers
Patterns of infection and day care utilization and risk of childhood acute lymphoblastic leukaemia.
Joseph P. Neglia,M S Linet,Xiao-Ou Shu,Richard K. Severson,John D. Potter,Ann C. Mertens,Wan-Qing Wen,J. H. Kersey,Leslie L. Robison +8 more
TL;DR: With one exception (ear infections), these data do not support the hypothesis that a decrease in the occurrence of common childhood infection increases risk of ALL.
Patterns of gonadal dysfunction following bone marrow transplantation.
TL;DR: Gonadal function in 270 patients who underwent bone marrow transplantation (BMT) between 1974 and 1988 was reviewed, and individuals who received radiation were more likely to develop an elevated FSH level over time than those who had received no preparative radiation treatment.
96
The contribution of Neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia
TL;DR: This multi‐site study examined the relative influence of neurocognitive functioning, steroid randomization, and demographic characteristics on QOL in first‐remission survivors of childhood ALL.
95
Maternal vitamin use and reduced risk of neuroblastoma.
TL;DR: The results of this study suggest that vitamin use during pregnancy might reduce incidence of neuroblastoma, consistent with findings for other childhood cancers.
93
Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study
Tara O. Henderson,Chaya S. Moskowitz,Joanne F. Chou,Angela R. Bradbury,Joseph P. Neglia,Chau T. Dang,Kenan Onel,Danielle Novetsky Friedman,Smita Bhatia,Louise C. Strong,Marilyn Stovall,Lisa B. Kenney,Dana Barnea,Elena Lorenzi,Sue Hammond,Wendy M. Leisenring,Leslie L. Robison,Gregory T. Armstrong,Lisa Diller,Kevin C. Oeffinger,Kevin C. Oeffinger +20 more
TL;DR: The data suggest high-dose alkylator and anthracycline chemotherapy increase the risk of breast cancer at a young age, and may suggest a possible underlying gene-environment interaction that warrants further study.
93